Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

The U.S. Department of Health and Human Services announced a $150 million investment to make monoclonal antibody therapeutic treatments available for patients in vulnerable communities nationwide.

The initiative is part of an effort to promote health equity in response to the COVID-19 pandemic, HHS announced March 17.

The funding is designed to increase administration of monoclonal antibody treatments in “hard-hit communities,” according to a news release. The therapy was made available on an emergency basis by the Food and Drug Administration and has been shown to be safe and effective at preventing hospitalization and death in patients with early-stage COVID-19. The National Institutes of Health recommends the treatments for non-hospitalized COVID-19 patients who are deemed to be at high risk of developing severe disease.

“Assistance may include additional staffing, infusion center capacity in traditional and non-traditional health care settings, and equipment to administer the intravenous infusion treatments,” HHS stated. “The effort will also increase awareness among health care providers and patients about the treatment options available, including where and how to access them.”

The announcement did not include information on the process by which funding will be allocated. Distributions will be made to communities that have a high prevalence of COVID-19 and are determined to be particularly at risk based on the CDC’s social vulnerability index, which uses 15 U.S. census variables to indicate vulnerable communities.

About the Author

Nick Hut

is a senior editor with HFMA, Westchester, Ill. (nhut@hfma.org).

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Care Management

News | Coronavirus

Healthcare News of Note: Hospital employment continues to decline despite an increase in jobs for the healthcare sector

A continuing drop in hospital job numbers, President Biden’s plans for the ACA and how COVID-19 affected stroke care during the pandemic are all topics covered in this week’s Healthcare News of Note.

Column | Innovation and Disruption

It's all in the breath: An argument for improved outcomes and reduced costs in healthcare

Effective breathing is known to promote good health, but our healthcare system has given relatively little attention to the concept of breathing therapy. COVID-19 has increased the need for a greater focus on this issue, and there are simple steps healthcare organizations can take to address it.

News | Innovation and Disruption

Healthcare News of Note: 14 healthcare providers unite to launch new data platform to glean more insight on medical conditions

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles, including the debut of a provider-led data platform, delayed care during the pandemic and the impact of the recent winter storm on Texas hospitals and health systems.

Executive Perspective | Social Determinants of Health

COVID-19 magnifies impact of SDOH on U.S. healthcare system

Population health management expert Jenifer Leaf Jaeger, MD, MPH, examines why the COVID-19 pandemic has made it more critical than ever for the U.S. providers to address the needs of people whose health and well-being are compromised by social determinants of health.